维普期刊资源整合服务平台（V6.5）

72篇 您的检索式：作者名="Vizzutti F"

选中清除导出查看参考文献查看引证文献引用追踪共4页首页上一页第1页下一页末页 /4 跳转

	题名	作者	年代	出处	被引量
1	Anti-VEFG receptor-2 monoclonal prevents portal-systemic collateral vessel formation in portal hypertensive mice显示文摘	FERNANDEZ M VIZZUTTI F GACIA-PAGAN JC	2004	Gastroenterology2004，126，3：	1
2	Liver stiffness measure ment predicts severe portaJ hypertension in patJents with HCV - related cirrhosis显示文摘	Vizzutti F Arena U Romanelli RG	2007	Hepatology2007，45，5：	1
3	Acute viral hepatitis increases liver stiffness values measured by transient elastography显示文摘	Arena U Vizzutti F Corti G	2008	Hepatology2008，47，2：	1
4	Elastography for the noninvasive assessment of liver disease:limitations and future developments 显示文摘	Vizzutti F Arena U Marra F	2009	Gut2009，58，2：	1
5	Anti-VEGF receptor-2 monoclonal antibody prevents portal- systemic collateral vessel formation in portal hypertensive mice 显示文摘	FERNANDEZ M VIZZUTTI F GARCIA- PAGAN J C	2004	Gastroenterol2004，126，：	1
6	Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice 显示文摘	Fernandez M Vizzutti F Garcia-Pagan JC	2004	Gastroenterology2004，126，3：	1
7	Transient elastography for the assessment of liver fibrosis in patients with chronic viral hepatitis: the missing tool?显示文摘	Stasi C Arena U Vizzutti F	2009	Dig Liver Dis2009，41，12：	1
8	Acute viral hepatitis in-creasesliver stiffness valuesmeasured by transient elastogra-phy显示文摘	Arena U Vizzutti F Corti G	2008	Hepatology2008，47，2：	1
9	Update on ascite and hepatorenal syndrome显示文摘	Gentilini P Vizzutti F Gentilini A	2002	Dig Liver Dis2002，34，8：	1
10	Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice 显示文摘	Fernandez M Vizzutti F Garcia-Pagan JC	2004	Gastroenterology2004，126，3：	1
11	Liver stiffness measurement predicts severe portal hypertension in patients with HCV-related cirrhosis显示文摘	Vizzutti F Arena U Romanelli RG	2007	Hepatology2007，45，5：	1
12	Anti-VEGF receptor-2 monoclonal antibody prevents portal-systemic collateral vessel formation in portal hypertensive mice显示文摘	Fernandez M Vizzutti F Garcia-Pagan JC		0，，：	1
13	Silybin,a component of sylimarin,exerts anti-inflammatory and anti-fibrogenic effects on human hepatic stellate cells显示文摘	Trappoliere M Caligiuri A Schmid M Bertolani C Failli P Vizzutti F Novo E di Manzano C Marra F Loguereio C Pinzani M		0，，：	1
14	Non-invasive assessment of fibrosis in non-alcoholic fatty liver disease显示文摘	Vizzutti F Arena U Nobili V	2009	Ann Hepatol2009，8，8：	1
15	Acute viral hepatitis increases liver stiffness values measured by transient elastography显示文摘	Arena U Vizzutti F Corti G	2008	Hcpa tology2008，47，2：	1
16	Liver stiffness measurement predicts severe portal hypertension in pa- tients with HCV-related cirrhosis显示文摘	Vizzutti F Arena U Romanelli RG	2007	Hepatology2007，45，5：	1
17	Non invasive diagnosis of portal hypertension in cirrhotic patients显示文摘	Vizzutti F Arena U Rega L	2005	Gastroenterologie Clinique et Biologique2005，29，10：	1
18	Accuracy and reproducibility of transient elastography for the diagnosis of fibrosis in pediatric nonalcoholic steatohepatitis显示文摘	Nobili V Vizzutti F Arena U		0，，02：	1
19	Update on ascites and hepatorenal syndrome显示文摘	Gentilini P Vizzutti F Gentilini A	2002	Dig Liver Dis2002，34，8：	1
20	Liver Stiffness Measurement predicts severe portal hypertension in patients with HCV - related cirrhosis 显示文摘	VIZZUTTI F ARENA U ROMANELL! R G	2007	Hepatology2007，45，5：	1

返回顶部每页显示：

共4页首页上一页第1页下一页末页 /4 跳转

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

用户提示